Search

everythinglearnresearchcommunity

for

Search:↓

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Being obese and eating too many calories may increase the risk of kidney cancer, but physical activity doesn't seem to affect this risk.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Using finasteride with TIP extends time off period for prostate cancer patients.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

Finasteride treats hair loss and reduces prostate cancer risk.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Ozone therapy might improve cancer treatment and reduce its side effects.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.